Adding fast‐acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18‐week, open‐label, phase 3 trial (onse...

por Rodbard, Helena W., Tripathy, Devjit, Vidrio Velázquez, Maricela, Demissie, Marek, Tamer, Søren C., Piletič, Milivoj
Publicado 2017